Shuotongo Ureteroscopy for Upper Urinary Tract Stones

Urinary Calculi Clinical Trial

— SFUUTS  

Official title:

Clinical Study on the Treatment of Upper Urinary Tract Stones by Shuotong Scope

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05712785
• Other study ID #: 20231925-1
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2020
• Est. completion date: December 20, 2026

Study information

• Verified date: March 2023
• Source: Handan First Hospital
• Contact: kunwu yan, Master
• Phone: +8618232053937
• Email: 1749200794[@]qq.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to use the Shuotong ureteroscopy for surgical treatment of patients with upper urinary tract stones, taking advantage of the fact that the Shuotong mirror can be used for simultaneous lithotripsy and stone removal, thus maximizing the discharge of stones from the body and improving the stone removal rate.

Description:

Ureteroscopy via the natural lumen has the advantages of being non-invasive, safe and repeatable. This is where Shuotongo ureteroscopy, a new type of ureteroscopy, has not yet become fully popular. Usually, most patients with upper urinary tract stones are treated by ureteroscopy or with flexible ureteroscopy, because these endoscopes usually break the stones and ask the patient to drink more water to expel the stones by themselves, after the operation, it is usually easy to leave stones in the body, and some patients even form stone streets to block the ureter again after the operation. In some patients, stones may form again and obstruct the ureter again. The Shuotong Ureteroscopy has the advantages of stone crushing and stone removal, which can synchronize the process of stone crushing and stone removal and maintain a good surgical view. It has the advantages of simple operation, less trauma and high safety for the operation via natural channel, especially for the large stones in the upper urinary tract and Gantun stones.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 200
• Est. completion date: December 20, 2026
• Est. primary completion date: December 20, 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• Clinical diagnosis of Ureteral calculus Must be able to cooperate with the treatment

Exclusion Criteria:

• Patients had severe urinary tract infections; patients had other conditions which investigators thought not suitable for the study.

Related Conditions & MeSH terms

• Calculi
• Urinary Calculi
• Urolithiasis

Intervention

Device:
• Use of shuotong ureteroscopy
Treatment of patients with ureteral stones using the Shuotong-scopy

Locations

Country	Name	City	State
China	Kunwu Yan	Handan	Hebei

Sponsors (1)

Lead Sponsor	Collaborator
Handan First Hospital

Country where clinical trial is conducted

China, 

References & Publications (3)

Gan S, Guo Z, Zou Q, Gu C, Xiang S, Li S, Ye Z, Wang S. Diagnosis accuracy of PCA3 level in patients with prostate cancer: a systematic review with meta-analysis. Int Braz J Urol. 2020 Sep-Oct;46(5):786-793. doi: 10.1590/S1677-5538.IBJU.2019.0521. — View Citation

Lai L, Zhang W, Zheng F, Wang T, Bai P, Liu Z, Zheng J, Shao Z, Duan B, Wang H, Xing J, Chen H, Huang Y, Chen B. Comparison of the Efficacy of ShuoTong Ureteroscopy and Simple Flexible Ureteroscopy in the Treatment of Unilateral Upper Ureteral Calculi. Fr — View Citation

Qiao D, Cheng L, Xiaomei T, Baolei S, Yingyi L, Hui Z, Shaohua B, Wei L, U DY, Fangqiong D, Jie L, Shuangning L. Effect of ultra-mini percutaneous nephrolithotomy and ShuoTong ureteroscopy on the stress response, inflammatory indices, and urokinase level — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Stone removal rate	Residual stones in the body after surgery	1 week after surgery
Secondary	Surgery time	Time from start of surgery to end of surgery	During surgery